| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 10.364 | 30.865 | 91.816 |
| Total Income - EUR | - | - | - | - | - | - | - | 10.364 | 30.865 | 91.816 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 3.283 | 11.163 | 46.533 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 7.081 | 19.702 | 45.283 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 6.777 | 16.260 | 43.093 |
| Employees | - | - | - | - | - | - | - | 0 | 0 | 1 |
Check the financial reports for the company - Alexco-Bioprod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 825 | 329 | 684 |
| Current Assets | - | - | - | - | - | - | - | 7.450 | 25.366 | 50.713 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 6.856 | 15.943 | 42.854 |
| Cash | - | - | - | - | - | - | - | 594 | 9.423 | 7.860 |
| Shareholders Funds | - | - | - | - | - | - | - | 6.817 | 16.301 | 43.141 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.458 | 9.394 | 8.256 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4322 - 4322" | |||||||||
| CAEN Financial Year |
4322
|
|||||||||
Comments - Alexco-Bioprod S.r.l.